Executive Board
The Executive Board has been established to assist the Chief Executive in leading The Institute of Cancer Research to achieve its strategic aims and objectives within the approved strategies and budgets and is responsible for formulating strategies, plans and budgets for approval by the Board of Trustees.
Professor Kristian Helin
Chief Executive and President

Carol Ford
Chief People Officer

Professor Kevin Harrington
Head of Division – Radiotherapy and Imaging

Professor Clare Isacke
Dean of Academic & Research Affairs

Paul Norris
Chief Financial Officer

Professor Jonathon Pines
Head of Division – Cancer Biology

Dr Barbara Pittam
Chief Research and Academic Officer

Dr Olivia Rossanese
Head of Division and Director – Cancer Therapeutics

Latest ICR News

Newly discovered role of enzyme could explain link between diabetes and cancer
Cell biologists have made a significant advance, uncovering the key role of an enzyme in determining the physical structure and behaviour of cancer cells, including how they spread.

ICR researcher awarded prestigious lectureship for practice-changing breast cancer research
Dr Maggie Cheang, a breast cancer researcher at The Institute of Cancer Research, London, has been awarded the prestigious CL Oakley lectureship.

Scientists find new way to predict how bowel cancer drugs will stop working
Scientists from The Institute of Cancer Research, London, have developed a tool that can predict how bowel cancer adapts to treatment – helping researchers to design new personalised drugs that will keep patients living well for longer.

ICR scientist wins highly regarded award for early-career biomedical researchers
Dr Stephen John Sammut, a Clinician Scientist at The Institute of Cancer Research, London, has been awarded one of the eight 2025 research prizes from the Lister Institute of Preventive Medicine.